Benutzerspezifische Werkzeuge

Publications till 1995

Habicht,A., Lindauer,M., Galmbacher,P., Rudy,W., Gebert,J., Schackert,H.K., Meuer,S.C., and
 Moebius,U. (1995). Development of immunogenic colorectal cancer cell lines for vaccination: expression of CD80 (B7.1) is not sufficient to restore impaired primary T cell activation in vitro. Eur. J. Cancer 31A, 2396-2402.

Gebert,J.F., Hahn,M., Kadmon,M., Herfarth,C., and Schackert,H.K. (1994). Identification of a novel germline mutation in a FAP family. Hum. Mol. Genet. 3, 1167-1168.

Schackert,H.K. and Frost,P. (1993). [Gene therapy of malignant tumors]. Chirurg 64, 678-683.

Schackert,H.K., Gebert,J., Ansorge,W., and Herfarth,C. (1993). [Molecular principles of carcinogenesis. Significance for prevention and early detection of solid malignant tumors]. Chirurg 64, 669-677.

Schackert,H.K., Fan,D., and Fidler,I.J. (1990). Transient inhibition of liver regeneration in mice by transforming growth factor-beta 1 encapsulated in liposomes. Cancer Commun. 2, 165-171.

Price,J.E., Aukerman,S.L., Ananthaswamy,H.N., McIntyre,B.W., Schackert,G., Schackert,H.K.,
and Fidler,I.J. (1989). Metastatic potential of cloned murine melanoma cells transfected with
activated c-Ha-ras. Cancer Res. 49, 4274-4281.

Schackert,H.K. and Fidler,I.J. (1989). Development of an animal model to study the biology
of recurrent colorectal cancer originating from mesenteric lymph system metastases. Int. J. Cancer 44, 177-181.

Schackert,H.K., Itaya,T., Schackert,G., Fearon,E., Vogelstein,B., and Frost,P. (1989). Systemic immunity against a murine colon tumor (CT-26) produced by immunization with syngeneic cells expressing a transfected viral gene product. Int. J. Cancer 43, 823-827.

Itaya,T., Schackert,H., and Frost,P. (1989). The potential immunoregulation of metastases: the use of transfection to produce immunogenic tumor cells. Prog. Clin. Biol. Res. 288, 271-279.

Fan,D., Price,J., Schackert,H., Seid,C., Wilmanns,C., Chakrabarty,S., and Fidler,I.J. (1989). Antiproliferative activity of liposome-encapsulated transforming growth factor-beta against MDA-MB-435 human breast carcinoma cells. Cancer Commun. 1, 337-343.

Fan,D., Chakrabarty,S., Seid,C., Bell,C.W., Schackert,H., Morikawa,K., and Fidler,I.J. (1989). Clonal stimulation or inhibition of human colon carcinomas and human renal carcinomas mediated by transforming growth factor-beta 1. Cancer Commun. 1, 117-125.

Schackert,H.K., Betzler,M., and Herfarth,C. (1988). [Immunotherapy in surgical cancer patients]. Chirurg 59, 317-322.

Schackert,H.K., Betzler,M., Zimmermann,G.F., Decker,R., Geelhaar,G.H., Edler,L., Hess,C., and Herfarth,C. (1986). The predictive role of delayed cutaneous hypersensitivity testing in postoperative complications. Surg. Gynecol. Obstet. 162, 563-568.

Schmidtler,J., Schwille,P.O., Schackert,H.K., and Gall,F.P. (1986). Pancreatic surgery, gastric secretion and ulcers in the rat. Increased ulcer development following pancreatic half resection or duct occlusion. Eur. Surg. Res. 18, 28-35.

Gebhardt,C., Gall,F.P., Rosch,W., and Schackert,H.K. (1982). [Anastomotic ulcer following Whipple’s operation with stomach preservation]. Zentralbl. Chir 107, 952-958.

Merz,W.E., Schmidt,W., Hilgenfeldt,U., Schackert,K., and Lenhard,V. (1976). Isolation of substances from crude preparation of human chorionic gonadotropin (hCG) which strongly inhibit the transformation of lymphocytes [proceedings]. Z. Immunitatsforsch. Immunobiol. 152, 286-289.

Schmidt,W., Lenhard,V., Schackert,K., and Runnebaum,B. (1976). [Inhibitory effect of estrogens and progestins on lymphocte transformation by mitogen and allogenic stimulation (proceedings)]. Z. Immunitatsforsch. Immunobiol. 152, 297-299.